Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 140: | Line 140: | ||
"RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure", | "RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure", | ||
"ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial", | "ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial", | ||
"B-CONVINCED" : "Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode", | |||
"EDIC" : "Epidemiology of Diabetes Interventions and Complications", | "EDIC" : "Epidemiology of Diabetes Interventions and Complications", | ||
"RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan", | "RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan", |